人类肝臟模型市场规模、份额和成长分析（按产品类型、应用、最终用户和地区划分）—2026-2033年产业预测

全球人类肝臟模型市场规模预计在 2024 年达到 13.8 亿美元，从 2025 年的 15.8 亿美元增长到 2033 年的 47.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 14.7%。

全球人工肝模型市场预计将迎来显着成长，主要受药物毒性测试需求不断增长以及减少动物实验的强烈推动。再生医学投资的增加和3D肝臟建模技术的进步也促进了这一成长。此外，肝臟疾病盛行率的上升以及对个人化医疗日益增长的关注，也加剧了对准确可靠的药物测试替代方案的需求。儘管前景光明，但仍存在诸多挑战，例如高成本、熟练人员短缺以及先进肝臟建模技术实施的复杂性。此外，监管障碍和模型检验的不一致可能会阻碍其广泛应用，进而影响区域市场渗透率和成长率。

全球人工肝模型市场驱动因素

对药物毒性进行精准快速评估的需求日益增长，是推动人类肝臟模型市场扩张的关键因素。这些模型具有更高的生理相关性和预测准确性，使製药公司能够在研发过程的早期阶段发现潜在的毒性。这项重要特性增强了药物候选物在各个研发阶段的推进信心，最终有助于更有效率、更有效地进行药物评估和核准。因此，製药业对改进调查方法的需求正在显着推动人类肝臟模型市场的成长。

限制全球人类肝臟模型市场的因素

全球人类肝臟模型市场面临的挑战在于，建造和维护先进的肝臟模型（包括晶片肝臟系统和3D列印组织）需要大量的资金投资。对专用设备、高技能人员和高品质材料的需求会导致高昂的成本，这对于预算有限的小规模实验室和机构而言难以承受。这种经济负担会阻碍市场进入和普及，尤其是在资源匮乏的发展中地区，从而限制了能够促进该领域研发的创新技术的应用。

全球人类肝臟模型市场趋势

受3D生物列印和晶片器官平台等技术进步的推动，全球人类肝臟模型市场正经历显着成长。这些创新技术提高了药物筛检的准确性，减少了对传统动物实验的依赖，并能更精确地模拟复杂的肝臟疾病。这项发展不仅简化了药物发现和开发流程，也有助于更有效地进行疾病研究，使人类肝臟模型成为製药和生物医学领域不可或缺的工具。此外，人们日益重视缓解与动物模型相关的伦理问题，进一步推动了对这些先进肝臟模型的需求，从而为市场带来了光明的前景。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球人类肝臟模型市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 二维模型
• 3D模型
• 晶片肝臟/微流体模型
• 离体/组织切片模型

全球人类肝臟模型市场规模（按应用及复合年增长率划分）（2026-2033 年）

• ADME 研究
• 毒理学/安全性测试
• 疾病模型
• 其他的

全球人类肝臟模型市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 製药和生物技术公司
• 受託研究机构（CRO）
• 学术和研究机构

全球人类肝臟模型市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• ATCC
• Merck KGaA
• AcceGen
• ZenBio, Inc.
• Organovo Holdings Inc.
• BioIVT
• InSphero
• CN Bio Innovations Ltd.
• STEMCELL Technologies
• ScienCell Research Laboratories, Inc.
• Emulate, Inc.
• Cyfuse Biomedical KK
• Mimetas
• Cellink
• PhoenixBio Co., Ltd.
• Thermo Fisher Scientific Inc.
• BICO Group
• Kirkstall Ltd.
• MATTEK（The BICO Group）
• HiREL

结论与建议

Global Human Liver Models Market size was valued at USD 1.38 Billion in 2024 and is poised to grow from USD 1.58 Billion in 2025 to USD 4.73 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The global human liver model market is poised for significant growth, driven by heightened demand for drug toxicity testing and a strong push towards minimizing animal testing. Factors such as increased investments in regenerative medicine and advancements in 3D liver modeling technologies are contributing to this expansion. Furthermore, the rising prevalence of liver diseases and the growing emphasis on personalized medicine are amplifying the necessity for precise and dependable drug testing alternatives. Despite this promising outlook, challenges remain, including the high costs associated with advanced liver model technologies, a shortage of skilled personnel, and the complex nature of implementation. Additionally, regulatory hurdles and inconsistencies in model validation may impede widespread adoption, potentially affecting market penetration and growth rates in various regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Liver Models market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Liver Models Market Segments Analysis

Global Human Liver Models Market is segmented by Product Type, Application, End-User and region. Based on Product Type, the market is segmented into 2D Models, 3D Models, Liver-on-a-Chip / Micro-fluidic Models and Ex-Vivo / Tissue Slice Models. Based on Application, the market is segmented into ADME Studies, Toxicology / Safety Testing, Disease Modelling and Others. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organisations (CROs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Liver Models Market

The increasing need for precise and prompt assessment of drug toxicity serves as a significant catalyst for the expansion of the human liver models market. These models provide enhanced physiological relevance and predictive accuracy, enabling pharmaceutical companies to detect potential toxicities earlier in the development process. This crucial capability allows for greater confidence in advancing drug candidates through various stages of development, ultimately contributing to more efficient and effective drug evaluation and approval. As a result, the market for human liver models is witnessing considerable growth, driven by the necessity for improved testing methodologies in the pharmaceutical industry.

Restraints in the Global Human Liver Models Market

The Global Human Liver Models market faces challenges due to the substantial financial investments required for the creation and maintenance of advanced liver models, including liver-on-a-chip systems and three-dimensional printed tissues. The need for specialized equipment, a highly skilled workforce, and quality materials can lead to significant costs that may be overwhelming for smaller laboratories or institutions with limited budgets. This financial burden can hinder market entry and accessibility, particularly in developing regions where resources are scarce, thus restricting the adoption of innovative technologies that could otherwise enhance research and development in the field.

Market Trends of the Global Human Liver Models Market

The Global Human Liver Models market is witnessing significant growth driven by technological advancements in 3D bioprinting and organ-on-a-chip platforms. These innovations enhance the precision of drug screening processes, minimizing reliance on traditional animal testing and enabling researchers to replicate intricate liver diseases more accurately. This evolution not only streamlines drug discovery and development but also supports more effective disease research, positioning human liver models as essential tools in pharmaceutical and biomedical fields. The emphasis on reducing ethical concerns associated with animal models further fuels the demand for these sophisticated liver models, indicating a promising trajectory for the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Human Liver Models Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• 2D Models
• 3D Models
• Liver-on-a-Chip / Micro-fluidic Models
• Ex-Vivo / Tissue Slice Models

Global Human Liver Models Market Size by Application & CAGR (2026-2033)

• Market Overview
• ADME Studies
• Toxicology / Safety Testing
• Disease Modelling
• Others

Global Human Liver Models Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organisations (CROs)
• Academic & Research Institutes

Global Human Liver Models Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• ATCC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organovo Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSphero
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CN Bio Innovations Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyfuse Biomedical K.K.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mimetas
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellink
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PhoenixBio Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BICO Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirkstall Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MATTEK (The BICO Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiREL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations